Our company is pioneering the next generation of molecular sensing technology with an AI-powered semiconductor platform designed for adaptive, real-time multi-omic detection. By integrating advanced semiconductor engineering with cutting-edge molecular biology, our platform enables precise detection and analysis of DNA, RNA, proteins, cells, and novel small molecules in a single, unified system.

At the core of our innovation is a high-resolution semiconductor chip with over 100 million sensing pixels, each capable of electronic molecule detection. Combined with a powerful AI engine, this platform delivers unparalleled sensitivity and scalability for dynamic molecular interrogation, transforming how researchers and clinicians approach multi-omics, drug discovery, and diagnostics.

Our platform is uniquely equipped for high-throughput and combinatorial screening, offering a versatile solution for applications ranging from targeted drug discovery to real-time pathogen detection. By bridging molecular sensing and AI, we aim to accelerate the development of transformative therapies, unlock new insights into disease biology, and redefine the future of precision medicine.